Andrea Neisser-Svae, Head of IBU Intensive Care & Emergency Medicine Octapharma Group

Our patients are critically ill patients that require immediate medical attention. Amongst the critical factors to take in consideration, high quality, safety, efficacy and tolerability products are of extreme importance.

Octapharma strives at developing the best emergency medicine products to treat patients in ICEM setting.

ICEM Portfolio

Tolerability and safety in plasma transfusion

Fast & safe restoration of coagulation balance


Safe coagulation control


Albumin – nature’s choice of colloid

About Octapharma : Intensive Care and Emergency Medicine

Octapharma's Intensive Care & Emergency Medicine (ICEM) Portfolio comprises human plasma and protein products for treating critically ill or injured patients in intensive care and emergency settings.

 

Our ICEM products are fast-acting and effective, as well as safe and well-tolerated by patients. Used by emergency medicine physicians and paramedicus around the world, every day they are helping to save lives and improve long-term patient outcome.

 

An Intensive Care Unit is a specialised section of a hospital that provides comprehensive and continuous care for persons who are critically ill.

 

Emergency Medicine focuses on diagnosis and treatment of acute illnesses and injuries that require immediate medical attention. While not usually providing long-term or continuous care, emergency medicine physicians and paramedics still aim to improve long-term patient outcome.

Octapharma is specialised in discovering, developing, improving and manufacturing plasma-derived products for coagulation restoration, and strives to develop the best emergency medicine products. Given the challenges of using blood components in ICEM, we have introduced a confidence-building concept in all our activities to support our partners in finding even more effective ways of using blood component therapies, thereby optimising safety and reducing costs.